Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Mina Hosseini, Zahra Habibi, Narges Hosseini, Sina Abdoli & Nima Rezaei. (2022) Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review. Expert Opinion on Biological Therapy 22:3, pages 349-366.
Read now
Read now
Huixue Wang, Jie Yang, Hui Pan, Mei Chee Tai, Mohamed H Maher, Renbing Jia, Shengfang Ge & Linna Lu. (2020) Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway. OncoTargets and Therapy 13, pages 3903-3920.
Read now
Read now
Jose M. Ayuso, Regan Truttschel, Max M. Gong, Mouhita Humayun, Maria Virumbrales-Munoz, Ross Vitek, Mildred Felder, Stephen D. Gillies, Paul Sondel, Kari B. Wisinski, Manish Patankar, David J. Beebe & Melissa C. Skala. (2019) Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model. OncoImmunology 8:3.
Read now
Read now
Wade Chun-Wai Suen, Wayne Yuk-Wai Lee, Kam-Tong Leung, Xiao-Hua Pan & Gang Li. (2018) Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials. Cancer Investigation 36:8, pages 431-457.
Read now
Read now
V. Leuci, M. Casucci, G. Grignani, R. Rotolo, U. Rossotti, E. Vigna, L. Gammaitoni, G. Mesiano, E. Fiorino, C. Donini, A. Pisacane, L. D. ambrosio, Y. Pignochino, M. Aglietta, A. Bondanza & D. Sangiolo. (2018) CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. OncoImmunology 7:5.
Read now
Read now
Markus Granzin, Ana Stojanovic, Matthias Miller, Richard Childs, Volker Huppert & Adelheid Cerwenka. (2016) Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma. OncoImmunology 5:9.
Read now
Read now
Myriam N. Bouchlaka, Kai D. Ludwig, Jeremy W. Gordon, Matthew P. Kutz, Bryan P. Bednarz, Sean B. Fain & Christian M. Capitini. (2016) 19F-MRI for monitoring human NK cells in vivo. OncoImmunology 5:5.
Read now
Read now
Sabrina Genßler, Michael C. Burger, Congcong Zhang, Sarah Oelsner, Iris Mildenberger, Marlies Wagner, Joachim P. Steinbach & Winfried S. Wels. (2016) Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival. OncoImmunology 5:4.
Read now
Read now
U. Koehl, C. Kalberer, J. Spanholtz, D. A. Lee, J. S. Miller, S. Cooley, M. Lowdell, L. Uharek, H. Klingemann, A. Curti, W. Leung & E. Alici. (2016) Advances in clinical NK cell studies: Donor selection, manufacturing and quality control. OncoImmunology 5:4.
Read now
Read now
Assaf Marcus & Zelig Eshhar. (2014) Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer. Expert Opinion on Biological Therapy 14:7, pages 947-954.
Read now
Read now
Cécile Badoual, Pierre-Louis Bastier, Hélène Roussel, Marion Mandavit & Eric Tartour. (2013) An allogeneic NK cell line engineered to express chimeric antigen receptors. OncoImmunology 2:11.
Read now
Read now
Natalia Lapteva, April G. Durett, Jiali Sun, Lisa A. Rollins, Leslie L. Huye, Jian Fang, Varada Dandekar, Zhuyong Mei, Kimberley Jackson, Juan Vera, Jun Ando, Minhtran C. Ngo, Elaine Coustan-Smith, Dario Campana, Susann Szmania, Tarun Garg, Amberly Moreno-Bost, Frits Vanrhee, Adrian P. Gee & Cliona M. Rooney. (2012) Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy 14:9, pages 1131-1143.
Read now
Read now
Christiane L. Mallett, Catherine Mcfadden, Yuhua Chen & Paula J. Foster. (2012) Migration of iron-labeled KHYG-1 natural killer cells to subcutaneous tumors in nude mice, as detected by magnetic resonance imaging. Cytotherapy 14:6, pages 743-751.
Read now
Read now
Laurent Boissel, Monica Betancur, Weiquan Lu, Winfried S. Wels, Teresa Marino, Richard A. Van Etten & Hans Klingemann. (2012) Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens. Leukemia & Lymphoma 53:5, pages 958-965.
Read now
Read now
Theresa L. Whiteside, Deborah L. Griffin, Joanna Stanson, William Gooding, David McKenna, Darin Sumstad, Diane Kadidlo, Adrian Gee, April Durett, Robert Lindblad, Deborah Wood & David Styers. (2011) Shipping of therapeutic somatic cell products. Cytotherapy 13:2, pages 201-213.
Read now
Read now
Melissa A. Geller, Sarah Cooley, Patricia L. Judson, Rahel Ghebre, Linda F. Carson, Peter A. Argenta, Amy L. Jonson, Angela Panoskaltsis-Mortari, Julie Curtsinger, David McKenna, Kathryn Dusenbery, Robin Bliss, Levi S. Downs & Jeffrey S. Miller. (2011) A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer. Cytotherapy 13:1, pages 98-107.
Read now
Read now
Brent A. Williams, Xing-Hua Wang & Armand Keating. (2010) Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays. Cytotherapy 12:7, pages 951-960.
Read now
Read now
Mario Milco D'Elios, Gianfranco Del Prete & Amedeo Amedei. (2009) New frontiers in cell-based immunotherapy of cancer. Expert Opinion on Therapeutic Patents 19:5, pages 623-641.
Read now
Read now